Alternative assets are the rage. A Double Eagle gold coin recently sold for a record $18.9 million. An NFT sold for over $69.3 million. And a little-known crypto called Polygon gave investors 11,026% in returns. But there’s one alternative asset that has received less attention. And it has shown impressive resilience during times of inflation and volatility. I call it a “Legacy Asset.” Just holding one of these recently gave a Saudi billionaire 624,999,900% in price appreciation. And Alice Walton, the richest woman in America, bought over $500 million worth of this Legacy Asset. She said, “it is hope, it’s opportunity.” And the Rothschild family, involved in international banking since the 18th century, has amassed a huge amount of this Legacy Asset. Why? Because Legacy Assets have shown some impressive metrics, consider this: Legacy Assets’ price appreciation has outpaced the S&P 500 by almost threefold from 1995 to 2020. In 2020 amid the pandemic, it trounced ten major asset classes according to Citi, many of which have been considered conventional “safety hedges.” In periods of inflation equal to or higher than 3.0% (now it’s doubled), Legacy Assets grew 23.2% on average and outpaced most other alternative assets. What makes this asset so safe? As the BBC explained, “Art has no correlation to the stock market; paintings can go up in value even when the market crashes.” That’s part of why the wealthy, from Rockafeller to Jeff Bezos, Bill Gates, and Oprah Winfrey, all invest in Legacy Assets. Moreover, according to Deloitte, the estimated wealth held in this asset will increase by $1 trillion in less than five years. Now, physicians can easily own Legacy Assets as well. Legacy Assets is another word for contemporary art. And as you’ve just seen, it’s one of the ultra-rich favorite assets. And while that’s great if you have millions in the bank, it creates a problem for most investors. Unless you’re as rich as a hedge fund manager like Steve Cohen—who owns over $1 billion in contemporary art, it might be impossible for you to invest in a $15,000,000 Picasso painting. But thanks to the JOBS Act of 2012, companies can now sell securities to the public via Regulation A. And Masterworks, a startup by Harvard, Princeton, and Columbia alum, gives physicians the chance to invest in real, physical art as securities. Masterworks can now sell physical artworks by Picasso, Banksy, or Basquiat via shares representing an investment in the artworks. All you have to do is access the Masterworks app, and you’ll be able to invest in these artworks by famous artists for as little as $20 a share. Own Legacy Assets with just a few clicks. The signup process is easy. All you need to do is input your basic information in the Masterworks.io app. Once you’ve signed up, click the “offerings” tab to see which acquisitions are open for investment. Masterworks’ private research team pours over 30,000 unique data points and gives physicians access to paintings that are most likely to show price appreciation. When you click on each listing of specific artworks, you will be able to see: Specific details on what makes this painting worth purchasing Historical price appreciation compared to similar works of the same artist The appraised value of the artwork The total value of the initial offering Amount of funds that have been raised (once an offering reaches 100%, it’s closed to new investors) Early investors already saw a 32% annualized return, net of fees, from a Banksy sale last year — twice what the S&P 500 showed during the same period. And in 2021, investors are scheduled to receive a 31% annualized return, net of fees, from the sale of a George Condo painting called “Staring Into Space.” That’s why the Masterworks app is available to physicians. It allows you to diversify your portfolio with an asset that was once reserved for the ultra-wealthy. It gives you the chance to create a legacy. Click this link and invest in Legacy Asset with the Masterworks.io app. Or call 203-518-5172 to learn more about the asset class, and go over your financial goals, risk tolerance, and other considerations with an art investment representative. Source